0001628280-26-032825
SEC filingUFP Technologies delivered modest top-line and bottom-line growth in Q1 FY2026, with revenue up 4.1% and net income up 1.8%, supported by medical-market strength and gross margin expansion to 28.8%; however, operating cash flow declined significantly year-over-year, reflecting working capital dynamics tied to higher sales volume and recent strategic activity.
Revenue for Q1 FY2026 totaled $154.2 million, an increase of 4.1% compared to $148.1 million in Q1 FY2025. This growth was primarily driven by increased sales to customers in the medical market, specifically within the Robotic Surgery, Patient Surfaces and Support, and Interventional and Surgical sub-markets. Gross profit rose to $44.4 million (up 5.2% year-over-year), and gross margin expanded to 28.8% from 28.5% in the prior-year quarter. Management attributes this margin improvement to enhanced operational efficiency in high-volume medical production, not broad-based pricing or product mix shifts.
Operating income increased 1.0% to $23.4 million, and operating margin remained stable at 15.2%. This reflects disciplined control over operating expenses amid revenue growth and ongoing investments in manufacturing capacity. Net income rose 1.8% to $17.5 million, and diluted earnings per share increased to $2.24 from $2.21. The modest growth in net income relative to gross profit suggests continued investment in infrastructure and support functions, consistent with management’s stated intent to scale operations sustainably.
Net cash provided by operating activities was $3.2 million in Q1 FY2026, a significant decrease from $13.8 million in Q1 FY2025. Management explains this decline as stemming from working capital movements — particularly a build in accounts receivable and inventory — directly tied to higher sales volume in March and absorption related to recent strategic activity. While near-term liquidity remains sufficient, management notes that longer-term liquidity is contingent upon future operating performance and continued access to its revolving credit facility.
UFP Technologies funds its operations, capital requirements, and growth plan through internally generated cash and bank credit facilities. Management expects existing resources — including the revolving credit facility and cash expected from operations — to be sufficient to meet cash flow needs, including anticipated capital expenditures, for at least the next twelve months. The company continues to add manufacturing capacity to enhance efficiencies and accommodate demand growth, reinforcing its focus on organic scalability. Any future expansion may also require additional financing, including new debt or equity, depending on strategic opportunities and market conditions.